Effect of cotton residues incorporation on soil properties, organic nitrogen fractions, and nitrogen-mineralizing enzyme activity under long-term continuous cotton cropping.

The objective of this experiment was to study the effect of cotton residues incorporation on soil properties, soil organic nitrogen (N) fractions, and N-mineralizing enzyme (protease, and urease) activity in the 0-40 cm soil layer in the long-term continuous cotton field. In this experiment, seven treatments, including cotton residues incorporation for 5, 10, 15 and 20 years (marked as 5a, 10a, 15a, and 20a) and continuous cropping for 5, 10 and 20 years (marked as CK5, CK10 and CK20) were conducted. The results showed that the soil organic carbon (C) and N increased gradually with the increase in the duration of continuous cropping with cotton residues incorporation. Compared with CK20, the 20a treatments reduced the content of amino acid N (AAN), ammonium N (AN), amino sugar N (ASN), hydrolysable unidentified N (HUN), and acid insoluble N (AIN) significantly by 48.6, 32.2, 96.9, 48.3, and 38.7%, respectively (p < 0.05). The activity of protease and urease in 20a treatments significantly increased by 53.4 and 53.1% respectively as compared to CK20 (p < 0.05). Soil organic C and N-mineralizing enzyme activity decreased with the increase in cropping duration in the absence of cotton residues incorporation, while the organic N increased slightly. In conclusion, cotton residues returning can increase the storage of soil organic C and N in long-term continuous cropping cotton field, and improve the soil quality and soil fertility of continuous cropping cotton field.

Farrerol alleviates high glucose-induced renal mesangial cell injury through the ROS/Nox4/ERK1/2 pathway.

Hyperproliferation and oxidative stress induced by hyperglycemia in mesangial cells plays crucial roles in the pathological process of diabetic nephropathy. Farrerol, isolated from rhododendron leaves, possesses broad anti-oxidative and anti-inflammatory properties towards several diseases, but its role in diabetic neuropathy remains unclear. The aim of this study was to evaluate the effects of farrerol in high glucose induced mesangial cell injury, and to explore underlying molecular mechanisms. Our results showed that high glucose in vitro conditions significantly stimulated cell proliferation, inflammatory cytokine secretion, extracellular matrix deposition, excessive oxidative stress, and NADPH oxidase activity in mesangial cells. Levels of NADPH oxidase 4 (Nox4) expression, ERK1/2 phosphorylation, and TGF-ß1/Smad2 activation were significantly induced by high glucose conditions in mesangial cells. Inversely, farrerol treatments at 40, 60, and 80 µM concentrations, dose-dependently alleviated this molecular damage by high glucose in mesangial cells. We also found that restoration of Nox4 expression abolished the protective effects of farrerol on high glucose-induced proliferation and reactive oxygen species generation. Furthermore, pretreatment with the Nox4 inhibitor diphenyliodonium or the ERK1/2 pathway inhibitor PD98059, displayed similar ameliorated effects of farrerol on high glucose-induced mesangial cell damage. Taken together, these data suggest that farrerol displays protective effects on high glucose induced mesangial cell injury, partly through the Nox4-mediated ROS/ERK1/2 signaling pathway. These observations may provide novel insights into the application of farrerol as a diabetic neuropathy treatment.